查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1434696

自动胰岛素输送系统市场：依疾病类型、分布划分 - 2024-2030 年全球预测

Automated Insulin Delivery System Market by Disease Type (Type I Diabetes, Type II Diabetes), Distribution (Diabetes Clinics, Hospital Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

自动胰岛素输送系统市场规模预计到2023年为8.2139亿美元，2024年达到9.0104亿美元，预计到2030年将达到15.7949亿美元，复合年增长率为9.79%。

自动胰岛素输送系统的全球市场

主要市场统计
基准年[2023] 82139万美元
预测年份 [2024] 90104万美元
预测年份 [2030] 15.7949亿美元
复合年增长率（%） 9.79%
自动胰岛素输送系统市场-IMG1

FPNV定位矩阵

FPNV 定位矩阵对于评估自动化胰岛素输送系统市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对自动胰岛素输送系统市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-自动胰岛素输送系统市场的市场规模与预测是多少？

2-在自动胰岛素输送系统市场的预测期内，需要考虑投资哪些产品、细分市场、应用和领域？

3-自动胰岛素输送系统市场的技术趋势和法律规范是什么？

4-自动胰岛素输送系统市场主要供应商的市场占有率为何？

5-进入自动胰岛素输送系统市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 糖尿病盛行率上升并加强宣传宣传活动
      • 改进了商用 AID 系统的管道和可用性
      • 开发 AID 系统以改善临床结果
    • 抑制因素
      • 血糖感测器校准、感测器耐用性和皮肤相关问题
    • 机会
      • 升级现有胰岛素帮浦并开发新产品
      • 增加製造创新胰岛素输送系统的研发活动
    • 任务
      • 对泵浦和感测器不准确或不可靠性的担忧
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章 自动胰岛素输送系统市场：依疾病类型

  • I型糖尿病
  • II型糖尿病

第七章 自动胰岛素输送系统市场：依分布

  • 糖尿病诊所
  • 医院药房
  • 零售药房

第八章美洲自动胰岛素输送系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太自动胰岛素输送系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲自动胰岛素输送系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第12章竞争产品组合

  • 主要公司简介
    • Abbott Laboratories
    • Animas Corporation
    • Becton, Dickinson and Company
    • Bigfoot Biomedical Inc.
    • Biocon Limited
    • Dexcom, Inc.
    • Diabeloop SA
    • DreaMed Diabetes Ltd.
    • Eli Lilly and Company
    • F. Hoffmann-La Roche Ltd.
    • Insulet Corporation
    • Medtronic PLC
    • Novo Nordisk A/S
    • Sanofi SA
    • Tandem Diabetes Care, Inc.
  • 主要产品系列

第十三章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-437517DB6E87

[188 Pages Report] The Automated Insulin Delivery System Market size was estimated at USD 821.39 million in 2023 and expected to reach USD 901.04 million in 2024, at a CAGR 9.79% to reach USD 1,579.49 million by 2030.

Global Automated Insulin Delivery System Market

KEY MARKET STATISTICS
Base Year [2023] USD 821.39 million
Estimated Year [2024] USD 901.04 million
Forecast Year [2030] USD 1,579.49 million
CAGR (%) 9.79%
Automated Insulin Delivery System Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Automated Insulin Delivery System Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Automated Insulin Delivery System Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Automated Insulin Delivery System Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Animas Corporation, Becton, Dickinson and Company, Bigfoot Biomedical Inc., Biocon Limited, Dexcom, Inc., Diabeloop S.A., DreaMed Diabetes Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Insulet Corporation, Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., and Tandem Diabetes Care, Inc..

Market Segmentation & Coverage

This research report categorizes the Automated Insulin Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Disease Type
    • Type I Diabetes
    • Type II Diabetes
  • Distribution
    • Diabetes Clinics
    • Hospital Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Automated Insulin Delivery System Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Automated Insulin Delivery System Market?

3. What are the technology trends and regulatory frameworks in the Automated Insulin Delivery System Market?

4. What is the market share of the leading vendors in the Automated Insulin Delivery System Market?

5. Which modes and strategic moves are suitable for entering the Automated Insulin Delivery System Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Automated Insulin Delivery System Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of diabetes coupled with increasing number of awareness campaigns
      • 5.1.1.2. Availability of improved pipelined and marketed AID systems
      • 5.1.1.3. Developments in AID systems with improved clinical outcomes
    • 5.1.2. Restraints
      • 5.1.2.1. Calibration of a glucose sensor, sensor durability, skin-related issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Up-gradation of existing insulin pumps and new product developmen
      • 5.1.3.2. Increasing R&D activities for the production of innovative insulin delivery systems
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding pump imprecision and sensor inaccuracy or unreliability
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Automated Insulin Delivery System Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Type I Diabetes
  • 6.3. Type II Diabetes

7. Automated Insulin Delivery System Market, by Distribution

  • 7.1. Introduction
  • 7.2. Diabetes Clinics
  • 7.3. Hospital Pharmacies
  • 7.4. Retail Pharmacies

8. Americas Automated Insulin Delivery System Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Automated Insulin Delivery System Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Automated Insulin Delivery System Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Abbott Laboratories
    • 12.1.2. Animas Corporation
    • 12.1.3. Becton, Dickinson and Company
    • 12.1.4. Bigfoot Biomedical Inc.
    • 12.1.5. Biocon Limited
    • 12.1.6. Dexcom, Inc.
    • 12.1.7. Diabeloop S.A.
    • 12.1.8. DreaMed Diabetes Ltd.
    • 12.1.9. Eli Lilly and Company
    • 12.1.10. F. Hoffmann-La Roche Ltd.
    • 12.1.11. Insulet Corporation
    • 12.1.12. Medtronic PLC
    • 12.1.13. Novo Nordisk A/S
    • 12.1.14. Sanofi S.A.
    • 12.1.15. Tandem Diabetes Care, Inc.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. AUTOMATED INSULIN DELIVERY SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AUTOMATED INSULIN DELIVERY SYSTEM MARKET DYNAMICS
  • FIGURE 7. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 10. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. AUTOMATED INSULIN DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE I DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE II DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 9. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 98. AUTOMATED INSULIN DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 99. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. AUTOMATED INSULIN DELIVERY SYSTEM MARKET LICENSE & PRICING